In a thrilling shootout, the Lions' dynamic duo of Jahmyr Gibbs and David Montgomery combined for 218 rushing yards and four touchdowns, leading Detroit to a historic 38-30 win over the Ravens.
Once the world's most formidable diplomatic duo, the US and UK have faced challenges that threaten their leadership role. Discover how their past shaped today's global dynamics and what it means for the future.
Cardi B and her daughter Kulture turn heads at New York Fashion Week! Twinning in stunning fur ensembles, this mother-daughter duo caught the spotlight at the Alexander Wang show, showcasing their fashion prowess alongside icons like Martha Stewart.
Discover how Google Translate is revolutionizing language learning with its new AI-powered features, offering personalized lessons and real-time conversation translations. Could this change the game for language learners?
In a highly anticipated match, Emma Raducanu and Carlos Alcaraz's doubles partnership was swiftly defeated by the top-seeded duo of Jessica Pegula and Jack Draper, who are now on a winning streak in the US Open.
In a groundbreaking move, the Duffer Brothers, creators of 'Stranger Things', are set to join Paramount Pictures under a four-year exclusive deal for film and TV projects. This partnership promises exciting new stories and a return to the big screen for the duo. As they transition from Netflix, fans can expect more from the beloved franchise and new original content.
Max Martin and his protégé Shellback have teamed up with Taylor Swift once again for her upcoming album. Discover the magic behind their musical reunion and test your knowledge on their incredible history!
Retro fans, rejoice! Heretic and Hexen have been remastered for modern consoles and PC. Experience the classic fantasy FPS duo with new features, multiplayer options, and more!
Nintendo of America has revealed an exciting new bundle featuring the Nintendo Switch 2 and Pokémon Legends: Z-A. Priced at $499.99, it launches on October 16th, just in time for Pokémon fans!
Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy is on hold due to safety issues. An FDA official warns the path to market approval is fraught with challenges, especially after patient deaths linked to liver injuries.
